These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12746374)

  • 1. Improving the mouse model for studying the efficacy of voriconazole.
    Graybill JR; Najvar LK; Gonzalez GM; Hernandez S; Bocanegra R
    J Antimicrob Chemother; 2003 Jun; 51(6):1373-6. PubMed ID: 12746374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined therapy in treatment of murine infection by Fusarium solani.
    Ruíz-Cendoya M; Mariné M; Guarro J
    J Antimicrob Chemother; 2008 Sep; 62(3):543-6. PubMed ID: 18495651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of voriconazole in treatment of systemic scedosporiosis in neutropenic mice.
    Capilla J; Serena C; Pastor FJ; Ortoneda M; Guarro J
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3976-8. PubMed ID: 14638514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy against murine-disseminated infection by Fusarium verticillioides.
    Ruíz-Cendoya M; Pastor J; Guarro J
    Mycopathologia; 2011 Mar; 171(3):171-5. PubMed ID: 20853029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of voriconazole in a murine model of invasive paecilomycosis.
    Rodríguez MM; Pastor FJ; Serena C; Guarro J
    Int J Antimicrob Agents; 2010 Apr; 35(4):362-5. PubMed ID: 20129763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of voriconazole in the treatment of emerging mycoses].
    Pastor FJ; Guarro J
    Rev Iberoam Micol; 2007 Sep; 24(3):228-32. PubMed ID: 17874861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antifungal therapy in a neutropenic murine model of Neoscytalidium dimidiatum infection.
    Ruíz-Cendoya M; Madrid H; Pastor J; Guarro J
    Int J Antimicrob Agents; 2010 Feb; 35(2):152-5. PubMed ID: 20005680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole and fungal keratitis: a report of two treatment failures.
    Giaconi JA; Marangon FB; Miller D; Alfonso EC
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):437-9. PubMed ID: 17238810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis.
    Serena C; Gilgado F; Mariné M; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2240-3. PubMed ID: 16723595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient.
    Vincent AL; Cabrero JE; Greene JN; Sandin RL
    Cancer Control; 2003; 10(5):414-9. PubMed ID: 14581897
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful voriconazole therapy of disseminated Fusarium verticillioides infection in an immunocompromised patient receiving chemotherapy.
    Sagnelli C; Fumagalli L; Prigitano A; Baccari P; Magnani P; Lazzarin A
    J Antimicrob Chemother; 2006 Apr; 57(4):796-8. PubMed ID: 16469850
    [No Abstract]   [Full Text] [Related]  

  • 12. International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole.
    Lortholary O; Obenga G; Biswas P; Caillot D; Chachaty E; Bienvenu AL; Cornet M; Greene J; Herbrecht R; Lacroix C; Grenouillet F; Raad I; Sitbon K; Troke P;
    Antimicrob Agents Chemother; 2010 Oct; 54(10):4446-50. PubMed ID: 20625156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating disseminated fusariosis: amphotericin B, voriconazole or both?
    Ho DY; Lee JD; Rosso F; Montoya JG
    Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successsful voriconazole treatment of disseminated fusarium infection in an immunocompromised patient.
    Consigny S; Dhedin N; Datry A; Choquet S; Leblond V; Chosidow O
    Clin Infect Dis; 2003 Jul; 37(2):311-3. PubMed ID: 12856225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of posaconazole as treatment and prophylaxis against Fusarium solani.
    Wiederhold NP; Najvar LK; Bocanegra R; Graybill JR; Patterson TF
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1055-9. PubMed ID: 20065054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Arikan S; Lozano-Chiu M; Paetznick V; Nangia S; Rex JH
    J Clin Microbiol; 1999 Dec; 37(12):3946-51. PubMed ID: 10565912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voriconazole. UK 109496.
    Drugs R D; 1999 Feb; 1(2):187-8. PubMed ID: 10566023
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of grapefruit juice on serum voriconazole concentrations in the mouse.
    Sugar AM; Liu XP
    Med Mycol; 2000 Jun; 38(3):209-12. PubMed ID: 10892988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole: therapeutic review of a new azole antifungal.
    Herbrecht R
    Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole.
    Klont RR; Eggink CA; Rijs AJ; Wesseling P; Verweij PE
    Clin Infect Dis; 2005 Jun; 40(12):e110-2. PubMed ID: 15909252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.